publication venue for
- Vemurafenib and Obinutuzumab as Frontline Therapy for Hairy Cell Leukemia.. 2. 2023
- Colistin Monotherapy versus Combination Therapy for Carbapenem-Resistant Organisms.. 2. 2022
- Low-Dose Decitabine versus Low-Dose Azacitidine in Lower-Risk MDS.. 1. 2022
- Harm-to-Benefit of Three Decades of Prostate Cancer Screening in Black Men.. 1. 2022
- Does Prophylaxis Prevent Recurrent Clostridioides difficile Infection?. 1. 2022